We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

241 hedge funds and large institutions have $328M invested in ImmunityBio in 2025 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 103 increasing their positions, 37 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

178% more repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 37

126% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 27

37% more capital invested

Capital invested by funds: $239M → $328M (+$88.5M)

15% more funds holding

Funds holding: 210 → 241 (+31)

4.74% more ownership

Funds ownership: 9.33% → 14.07% (+4.7%)

3% less call options, than puts

Call options by funds: $11.9M | Put options by funds: $12.2M

Holders
241
Holders Change
+31
Holders Change %
+14.76%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
61
Increased
103
Reduced
37
Closed
27
Calls
$11.9M
Puts
$12.2M
Net Calls
-$313K
Net Calls Change
+$5.37M

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$22.1M
2
AC
Armistice Capital
New York
+$20.9M
3
Jane Street
Jane Street
New York
+$20.4M
4
BlackRock
BlackRock
New York
+$12M
5
AC
AlphaCore Capital
California
+$8M

Top Sellers

Rank Fund Capital Flow
1
Verition Fund Management
Verition Fund Management
Connecticut
-$1.56M
2
Group One Trading
Group One Trading
Illinois
-$1.53M
3
HF
HRT Financial
New York
-$715K
4
UBS Group
UBS Group
Switzerland
-$666K
5
Citigroup
Citigroup
New York
-$612K
Name Holding Trade Value Shares
Change 		Change in
Stake
EP
226
Essential Partners
California
$391 +$398 +148 New
GC
227
Gould Capital
Washington
$309 – – –
MSG
228
Main Street Group
Virginia
$135 +$137 +51 New
MSWA
229
Marshall & Sterling Wealth Advisors
New York
$132 – – –
AssetMark Inc
230
AssetMark Inc
California
$127 +$129 +48 New
FFO
231
Fortitude Family Office
Arizona
$116 +$118 +44 New
HWM
232
HighMark Wealth Management
Minnesota
$106 – – –
TWD
233
True Wealth Design
Ohio
$53 +$32 +12 +150%
JWA
234
JFS Wealth Advisors
Pennsylvania
$30 -$83 -31 -74%
DPW
235
DiNuzzo Private Wealth
Pennsylvania
$27 – – –
BHWM
236
Bay Harbor Wealth Management
Maryland
$23 +$8 +3 +50%
PWM
237
Parkworth Wealth Management
California
$18 – – –
HIA
238
HFM Investment Advisors
New Jersey
$11 -$5 -2 -33%
RWM
239
Rialto Wealth Management
New York
$11 +$11 +4 New
HF
240
HRT Financial
New York
– -$715K -237,761 Closed
RAM
241
Readystate Asset Management
Illinois
– -$376K -124,885 Closed
CM
242
Capula Management
Cayman Islands
– -$314K -104,380 Closed
DIG
243
Dauntless Investment Group
New Hampshire
– -$283K -94,141 Closed
CF
244
Corebridge Financial
Texas
– -$225K -74,873 Closed
Balyasny Asset Management
245
Balyasny Asset Management
Illinois
– -$169K -56,165 Closed
SP
246
SIH Partners
Delaware
– -$139K -46,017 Closed
ETC
247
Exchange Traded Concepts
Oklahoma
– -$132K -43,776 Closed
SG Americas Securities
248
SG Americas Securities
New York
– -$127K -42,188 Closed
ACM
249
Aster Capital Management
United Arab Emirates
– -$44.3K -13,463 Closed
Dimensional Fund Advisors
250
Dimensional Fund Advisors
Texas
– -$40.1K -13,328 Closed
7 8 9
10
11

IBRX Hedge Fund Activity: Q2 2025 in Review

241 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q2 2025, worth a combined $328M — up 37% from $239M a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new IBRX positions and 27 closed out — a net gain of 34 holders — while 103 added to existing stakes and 37 trimmed.

The largest buyer was Bank of America, adding an estimated $22.1M. The largest seller was Verition Fund Management, cutting an estimated $1.56M.

  • 241 institutional investors held ImmunityBio (IBRX) as of Q2 2025, up from 210 in Q1 2025.
  • Funds reported $328M of ImmunityBio stock for Q2 2025, up 37% quarter-over-quarter.
  • 61 funds opened new ImmunityBio positions in Q2 2025 and 27 closed out, a net change of +34 holders.
  • The largest ImmunityBio buyer in Q2 2025 was Bank of America, an estimated $22.1M added.
  • The largest ImmunityBio seller in Q2 2025 was Verition Fund Management, an estimated $1.56M sold.

Based on aggregated 13F filings for Q2 2025.